ライフサイエンスコーパス: reinfect

1 roliferative potential and the ability to be reinfected.

2 previously infected persons, 40 (2.5%) were reinfected.

3 viduals are repeatedly infected, treated and reinfected.

4 and 19% of those with primary infection were reinfected.

5 ment but were lost to follow-up, and one was reinfected.

6 eligmosomoides polygyrus infection and later reinfected.

7 esponses, suggesting that they were also not reinfected.

8 Twenty-eight participants were reinfected (12.3 cases/100 person-years; 95% confidence

9 women treated for Chlamydia trachomatis are reinfected 3 to 4 months after treatment, suggesting the

10 l dose of H. capsulatum (1 x 10(5)) and then reinfected 3 wk later with a lethal dose of H. capsulatu

11 infected with RSV as neonates or adults and reinfected 5 weeks later.

12 d shortly after birth or at weaning and were reinfected 5 wk later, followed by assessment of airway

13 ch they need to survive before the chance of reinfecting a new host occurs.

14 creased in lungs exposed to RSV in utero and reinfected after birth, and blocking TrkA signaling inhi

15 fected with Delta and exposed to BA.1 became reinfected, although they shed less virus than BA.1-infe

16 mL from the same donor, X355 was transiently reinfected and again rapidly lost all HCV markers.

17 re drug-cured of initial infection and later reinfected and treated with anti-IL-4R mAb, an antagonis

18 in characteristics of RSV is that it readily reinfects and causes disease throughout life without the

19 amma-producing T cells were 2-fold higher in reinfected animals (P = .018).

20 V-specific T-cell responses were elevated in reinfected animals after subsequent exposure to HEV.

21 The 4 reinfected animals showed a lower HEV-IgG avidity index

22 ion gradient were observed between naive and reinfected animals, indicating that the skewing of mRNA

23 ewer of the originally infected sites became reinfected at 12 months despite lack of maintenance ther

24 ly infected with RSV at 1 wk of age and were reinfected at 6 wk of age.

25 s are only partially immune (ie, they can be reinfected, but infections are usually abbreviated and l

26 rs at the time of initial infection, 6% were reinfected by 6 months, 11% by 1 year, and 17% by 2 year

27 -Score; 33%-55%) were estimated to have been reinfected by 9-weeks.

28 in the gastrointestinal tract and can become reinfected by autoinoculation from that site.

29 nd and Cambodia who were classified as being reinfected by the standard polymerase chain reaction pro

30 The proportion of reinfected children was high (81%) and there was cluster

31 Reinfected children were approximately 5 times less like

32 e most common symptoms in first-positive and reinfected CYP 12-months post-testing were tiredness (35

33 first-time PCR-test-positive and PCR-proven reinfected CYP at time of testing and at 3-, 6- and 12-m

34 45) of first-positives and 7.5 % (27/360) of reinfected CYP experienced cognitive impairment with no

35 s, were 15-to-17-years-old as were 33.3 % of reinfected CYP experiencing cognitive impairment (p < 0.

36 onths, 17.4% of first-positives and 21.9% of reinfected CYP fulfilled the research consensus Long Cov

37 little difference between first-positive and reinfected CYP with respect to symptom profiles and impa

38 th no differences between first-positive and reinfected CYP.

39 Eighteen subjects became reinfected during follow-up; this coincided with a subse

40 Of 349 827 eligible adults, 2583 were reinfected during July 2021-November 2021.

41 ry syncytial virus (RSV) readily infects and reinfects during infancy and throughout life, despite ma

42 virus is reactivated from neural fibers and reinfects epithelial cells.

43 fected with hepatitis C virus (HCV) could be reinfected, even with the original infecting strain.

44 ead, intracellular toxoplasmas replicate and reinfect, eventually lysing the macrophage population.

45 Clearly, many women become reinfected from an untreated partner; however, we propos

46 lled treponemes (NI/HKTP), and an immune and reinfected group (I/TP).

47 nstead, patients on HD who went on to become reinfected had mounted highly variable and sometimes rob

48 esulting in emergence of new strains able to reinfect hosts immune to previously circulating viruses.

49 ngs indicate that HERV-K remained capable of reinfecting humans through very recent evolutionary time

50 an endogenous retrovirus that is capable of reinfecting humans today.

51 he human population, regularly infecting and reinfecting humans while typically causing asymptomatic

52 in the dry season were less likely to become reinfected in the subsequent rainy season than those wit

53 This allows the virus to reinfect individuals that have acquired immunity to prev

54 Rapidly reinfected individuals did not have the positive treatme

55 Respiratory syncytial virus (RSV) reinfects individuals repeatedly.

56 ntestinal villi, is shed into the lumen, and reinfects intestinal immune cells that traffic to liver

57 All groups were reinfected intraperitoneally, 30 days later, with a leth

58 already seropositive individuals were likely reinfected, leading to an overall seropositivity of 96.0

59 sis to determine the history and ancestry of reinfecting lineages.

60 s become infected with HCV, and 10 to 25% of reinfected livers develop cirrhosis within 5 years.

61 which CNS reservoirs of HIV-1 could directly reinfect lymphoid tissue without being exposed to circul

62 lies, and bacteria isolated from flies could reinfect mammalian macrophages.

63 Reinfected mice developed enhanced IgG2b, IgG2a, and IgG

64 hin the lungs of influenza -virus immune and reinfected mice.

65 ach phenotype were isolated and then used to reinfect naive mice.

66 ticks, persisting through tick molting, and reinfecting new mammalian hosts.

67 Reinfecting parasites with the pfmdr1 N86/184F/D1246 hap

68 apidly mount effector functions to eliminate reinfecting pathogens in a strictly Ag-dependent fashion

69 22 (59%) remained HBsAg negative, and all 9 reinfected patients were HBV-DNA positive before treatme

70 neous viral clearance was observed in 83% of reinfected patients.

71 of a reservoir of HIV that could potentially reinfect peripheral tissues.

72 ting a potential for virus within the CNS to reinfect peripheral tissues.

73 should assess risk of severe outcomes among reinfected persons as new variants emerge, infection- an

74 retreatment more promptly than participants reinfected post-SVR (respectively, 471 vs 784 days on av

75 g the virus population to evade immunity and reinfect previously infected individuals.

76 m to evade immunity in their human hosts and reinfect previously infected individuals.

77 Reinfecting SARS-CoV-2 viral genomes largely mirror cont

78 Nucleotide and amino acid changes in the reinfecting sequence were compared with both the initial

79 persistence, characterizing the hallmarks of reinfecting sequences and the rate of viral evolution in

80 ted and lineage-1 underrepresented among the reinfecting strains (P = .004).

81 % of previously infected women do not become reinfected strongly suggests a role for an adaptive immu

82 iral pseudoparticles were detected in 60% of reinfected subjects; cross-reactive nAbs are rarely dete

83 s (RSV) causes disease early in life and can reinfect symptomatically throughout life without undergo

84 virus did not alter its host range and could reinfect T cells as well as primary astrocytes.

85 he most recent infection was higher in those reinfected than in those with a single infection (weight

86 eir most recent infection was lower in those reinfected than those with a single infection (weighted

87 y pass into the environment and may possibly reinfect the animal.

88 iding immunity against common pathogens that reinfect the host or are generated by repeated vaccinati

89 t lineages in a single patient were found to reinfect the new liver.

90 amphibian skin, daughter zoospores can then reinfect the same individual or find a new host.(5) Alth

91 o show that HERV-K replicated as a virus and reinfected the germline of the common ancestor of the fo

92 that escaped the humoral immune response and reinfected the liver graft of transplant patients, it ma

93 al villi into the small intestinal lumen and reinfected the Peyer's patches.

94 To address this question, we have reinfected the same set of D. melanogaster lines with Se

95 II.4 genotype can persist over long periods, reinfecting the population.

96 lthough the new liver is known to be rapidly reinfected, the dynamics and source of the reinfecting v

97 e immunity, as individuals can be repeatedly reinfected throughout life.

98 ot differ by the severity of reinfection and reinfecting variants were similar to the contemporaneous

99 Nine (69.2%) of these cases were reinfected versus 20 (35.7%) in the group that received

100 The reinfecting viral sequences had a median of 17.5 nucleot

101 y reinfected, the dynamics and source of the reinfecting virus(es) are unclear, resulting in some con

102 isingly, approximately 50% of animals became reinfected when homologously challenged with MoPn, altho

103 n, with HCV eradication achieved, but became reinfected with a different HCV strain after treatment.

104 evolved MDR-TB de novo and 6 as having been reinfected with a different strain.

105 Eleven percent of the patients were reinfected with a genetically different strain following

106 9% lower (aHR: 0.51, 95% CI: 0.27-0.94) when reinfected with a heterologous HCV genotype.

107 ity to clear one HCV strain, patients may be reinfected with a heterologous strain that can then pers

108 infection (day 180), BJAB cells could not be reinfected with adenovirus, even when CAR was reintroduc

109 e, gammadelta T cells from the lungs of mice reinfected with B. pertussis produced significantly more

110 Hamsters reinfected with BA.1 after prior Delta infection emitted

111 xposed to bacille Calmette-Guerin (BCG) were reinfected with BCG, were treated either with tenofovir

112 Two infants were infected and reinfected with different RSV-A strains during the same

113 ants were viremic at later follow-up: 2 were reinfected with different strains, 1 had a late treatmen

114 gocytophilum for the first time than in mice reinfected with either homologous or heterologous isolat

115 thin some serovars, 10 of 15 subjects became reinfected with gonococci expressing identical Por prote

116 with HIV are decreased when individuals are reinfected with HCV following treatment.

117 C Injection Drug User Cohort Study who were reinfected with HCV from 2009 to 2012.

118 e sustained virologic response (SVR) or were reinfected with HCV post-SVR.

119 nown that the rabbit model and humans can be reinfected with heterologous isolates.

120 l exhaustion, and in individuals chronically reinfected with malaria.

121 Ninety-four percent of the children were reinfected with P. vivax during biweekly follow-ups for

122 Individuals are reinfected with respiratory syncytial virus (RSV) repeat

123 timates the proportion of persons who became reinfected with SARS-CoV-2 during the Omicron wave in Ic

124 fection with the Omicron variant and 360 CYP reinfected with the Omicron variant completed an online

125 m falciparum (Pf) in individuals chronically reinfected with the parasite.

126 ice leads to exacerbated disease if mice are reinfected with the same virus as adults.

127 9% (0.36% to 1.18%) in participants who were reinfected with the SARS-CoV-2 virus (n=28 207; 5174 nir

128 Cases of persons reinfected with the virus are being reported with increa

129 s provide protection in chimpanzees serially reinfected with the virus.

130 more likely to be asymptomatic when they are reinfected with Treponema pallidum.

131 V) infects and causes disease in infants and reinfects with reduced disease throughout life without s

132 Case-patients were reinfected within 1 year; controls remained HCV-negative

133 transmission was high: 54.8% and 91.1% were reinfected within 6 and 18 months, respectively.